Oral squamous cell carcinoma associated with proliferative verrucous leukoplakia compared with conventional squamous cell carcinoma—a clinical, histologic and immunohistochemical study

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology - Tập 119 Số 3 - Trang 318-325 - 2015
Sharon Akrish1,2,3, Ofer Ben‐Izhak2,3, Edmond Sabo2,3, Adi Rachmiel1,3
1Rambam Medical Center, Department of Oral and Maxillofacial Surgery, Bat Galim, Haifa, Israel
2Rambam Medical Center, Department of Pathology, Bat Galim, Haifa, Israel
3Technion School of Medicine, Bat Galim, Haifa, Israel

Tóm tắt

Từ khóa


Tài liệu tham khảo

2005

Bagan, 2010, Proliferative verrucous leukoplakia: a concise update, Oral Dis, 16, 328, 10.1111/j.1601-0825.2009.01632.x

Reichart, 2003, Proliferative verrucous leukoplakia. Report of five cases, Mund Kiefer Gesichtschir, 7, 164, 10.1007/s10006-003-0472-1

Bagan, 2003, Proliferative verrucous leukoplakia: high incidence of gingival squamous cell carcinoma, J Oral Pathol Med, 32, 379, 10.1034/j.1600-0714.2003.00167.x

Murrah, 1994, Proliferative verrucous leukoplakia and verrucous hyperplasia, Ann Otol Rhinol Laryngol, 103, 660, 10.1177/000348949410300816

Morton, 2007, Proliferative verrucous leukoplakia and its progression to squamous cell carcinoma: report of three cases, J Oral Pathol Med, 36, 315, 10.1111/j.1600-0714.2007.00499.x

Hansen, 1985, Proliferative verrucous leukoplakia. A long term study of thirty patients, Oral Surg Oral Med Oral Pathol, 60, 285, 10.1016/0030-4220(85)90313-5

Kresty, 2008, Frequent alterations of p16ink4 a and p14arf in oral proliferative verrucous leukoplakia, Cancer Epidemiol Biomarkers Prev, 17, 3179, 10.1158/1055-9965.EPI-08-0574

Gondalfo, 2009, Proliferative verrucous leukoplakia: a potentially malignant disorder involving periodontal sites, J Periodontol, 80, 274, 10.1902/jop.2009.080329

Batsakis, 1999, Proliferative verrucous leukoplakia and its related lesions, Oral Oncol, 35, 354, 10.1016/S1368-8375(99)00007-X

Woolgar, 1995, Prediction of cervical lymph node metastasis in squamous cell carcinoma of the tongue/floor of mouth, Head Neck, 17, 463, 10.1002/hed.2880170603

Cerero-Lapidedra, 2010, Proliferative verrucous leukoplakia: a proposal for diagnostic criteria, Med Oral Pathol Oral Cir Bucal, 15, 839, 10.4317/medoral.15.e839

Carrard, 2013, Proliferative verrucous leukoplakia: a critical appraisal of the diagnostic criteria, Med Oral Pathol Oral Cir Bucal, 18, 411, 10.4317/medoral.18912

Silverman, 1984, Oral leukoplakia and malignant transformation, Cancer, 53, 563, 10.1002/1097-0142(19840201)53:3<563::AID-CNCR2820530332>3.0.CO;2-F

Silverman, 1997, Proliferative verrucous leukoplakia: a follow-up study of 54 cases, Oral Surg Oral Med Oral Pathol Oral Radiol Oral Endod, 84, 154, 10.1016/S1079-2104(97)90062-7

Ogus, 1978, Carcinoma of the dorsum tongue: a rarity or misdiagnosis, Br J Oral Surg, 16, 115, 10.1016/0007-117X(78)90021-5

1995, 296

Kari, 1997, Carcinoma of the oral tongue in northern Finland: trends in overall incidence and patient and tumor characteristics, J Oral Pathol Med, 26, 480, 10.1111/j.1600-0714.1997.tb00020.x

Slaughter, 1953, Field cancerization in oral stratified squamous cell carcinoma: clinical implications of multicentric origins, Cancer, 6, 963, 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q

Braakhuis, 2003, A genetic explanation of Slaughters’ concept of field cancerization: evidence and clinical implications, Cancer Res, 63, 1727

Lewin, 1998, Smoking tobacco, oral snuff, and alcohol in the aetiology of squamous cell carcinoma of the head and neck, Cancer, 82, 1367, 10.1002/(SICI)1097-0142(19980401)82:7<1367::AID-CNCR21>3.0.CO;2-3

Forastiere, 2001, Head and neck cancer, N Engl J Med, 345, 1890, 10.1056/NEJMra001375

Bagan, 2004, Proliferative verrucous leukoplakia: unusual locations of oral squamous cell carcinomas, and field cancerization as shown by appearance of multiple OSCCs, Oral Oncol, 40, 440, 10.1016/j.oraloncology.2003.10.008

Kademani, 2007, Analysis of death certification in patients with early stage oral cavity squamous cell carcinoma, J Oral Maxillofac Surg, 65, 1191, 10.1016/j.joms.2006.09.009

Larsen, 2009, The prognostic significance of histologic features in oral squamous cell carcinoma, J Oral Pathol Med, 38, 657, 10.1111/j.1600-0714.2009.00797.x

Nigro, 1989, Mutations in the p53 gene occur in diverse human tumour types, Nature, 342, 705, 10.1038/342705a0

Prosser, 1990, Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours, Oncogene, 5, 1573

Marks, 1991, Overexpression and mutation of p53 in epithelial ovarian cancer, Cancer Res, 51, 2979

Takahashi, 1989, P53: a frequent target for genetic abnormalities in lung cancer, Science, 246, 491, 10.1126/science.2554494

Finlay, 1988, Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life, Mol Cell Biol, 8, 531, 10.1128/MCB.8.2.531

Davidoff, 1991, Maintenance of p53 alterations throughout stages of breast cancer progression, Cancer Res, 51, 2605

Kohler, 1992, Overexpression and mutation of p53 in endometrial carcinoma, Cancer Res, 52, 1622

Levine, 1991, The p53 tumour suppressor gene, Nature, 351, 453, 10.1038/351453a0

Acin, 2011, Gain-of-function mutant p53 but not p53 deletion promotes head and neck cancer progression in response to oncogenic K-ras, J Pathol, 4, 479, 10.1002/path.2971

Olivieira, 2011, Prognostic significance of immunohistochemical biomarkers in oral squamous cell carcinoma head and neck, Oncology, 40, 298

Shin, 1996, p53 expressions: predicting recurrence and second primary tumors in head and neck squamous cell carcinoma, J Natl Cancer Inst, 88, 519, 10.1093/jnci/88.8.519

Myoung, 2006, Correlation of proliferative markers (Ki67 and PCNA) with survival and lymph node metastasis in oral squamous cell carcinoma: a clinical and histopathological analysis of 113 patients, Int J Oral Maxillofac Surg, 35, 1005, 10.1016/j.ijom.2006.07.016

Xie, 1999, Prognostic significance of proliferative and apoptotic markers in oral tongue squamous cell carcinomas, Oral Oncol, 35, 502, 10.1016/S1368-8375(99)00024-X

Syrjanen, 2010, The role of human papillomavirus infection in head and neck cancers, Ann Oncol, 243, 10.1093/annonc/mdq454

Kong, 2007, p16 INK4 A immunohistochemistry is superior to HPV in situ hybridization for the detection of high risk HPV in atypical squamous metaplasia, Am J Surg Pathol, 31, 33, 10.1097/01.pas.0000213347.65014.ee

Duncan, 2013, P16 immunohistochemistry can be used to detect human papillomavirus in oral cavity squamous cell carcinoma, J Oral Maxillofac Surg, 71, 1367, 10.1016/j.joms.2013.02.019

Gopalakrishnan, 1997, Mutated and wild type p53 expression and HPV integration in proliferative verrucous leukoplakia and oral squamous cell carcinoma, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 4, 471, 10.1016/S1079-2104(97)90148-7

Bagan, 2007, Lack of association between proliferative verrucous leukoplakia and human papillomavirus infection, J Oral Maxillofac Surg, 65, 46, 10.1016/j.joms.2005.12.066

Campisi, 2004, Proliferative verrucous versus conventional leukoplakia: no significantly increase of HPV infection, Oral Oncol, 40, 835, 10.1016/j.oraloncology.2004.02.007

Fettig, 2000, Proliferative verrucous leukoplakia of the gingiva, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 90, 723, 10.1067/moe.2000.108950

Palefsky, 1995, Association between proliferative verrucous leukoplakia and infection with human papillomavirus type 16, J Oral Pathol Med, 24, 193, 10.1111/j.1600-0714.1995.tb01165.x